Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Leukemia, Myeloid, Acute 176Leukemia 148Myelodysplastic Syndromes 140Precursor Cell Lymphoblastic Leukemia-Lymphoma 113Lymphoma 101Lymphoma, Non-Hodgkin 87Multiple Myeloma 83Hodgkin Disease 75Leukemia, Lymphocytic, Chronic, B-Cell 70Congenital Abnormalities 63Leukemia, Myeloid, Chronic-Phase 60Myeloproliferative Disorders 57Lymphoma, Large B-Cell, Diffuse 57Neoplasms, Plasma Cell 54Leukemia, Myelomonocytic, Chronic 53Leukemia, Myeloid, Accelerated Phase 53Lymphoma, Follicular 52Lymphoma, Mantle-Cell 48Burkitt Lymphoma 47Lymphoma, B-Cell, Marginal Zone 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 45Lymphoma, Large-Cell, Immunoblastic 44Blast Crisis 44Anemia, Refractory, with Excess of Blasts 43Primary Myelofibrosis 40Recurrence 37Hematologic Neoplasms 35Graft vs Host Disease 35Myelodysplastic-Myeloproliferative Diseases 34Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 32

Interventions

venetoclax 1fludarabine 1Influenza Vaccines 1Decitabine 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Older Patients × Busulfan × Clear all
NCT07052422 2025-07-04

VEN+DAC+Bu2Flu4 vs Bu2Flu5 Conditioning Regimen for Elderly Myeloid Malignancies Undergoing Allo-HSCT

Nanfang Hospital, Southern Medical University

Phase 2/3 Not yet recruiting
160 enrolled
Other neoplasm

Older Patients

Data powered by HemOnc (CC BY 4.0) Colophon âš¡